Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $10+, returning 10,416.5%.

ASSET	% RETURN
Regencell Bioscience (RGC)	10,416.47%
CannBioRx Life Sciences (ATNFW)	4,287.76%
WW International, Inc Common Stock (WW)	2,334.35%
DeFi Development (DFDV)	2,280.74%
Zepp Health (ZEPP)	1,630.77%
Diginex Limited Ordinary Shares (DGNX)	1,320.19%
FiEE (FIEE)	1,138.53%
Asset Entities Inc Class B Common Stock (ASST)	1,130%
Abivax SA American Depositary Shares (ABVX)	1,019.2%
Oncology Institute (TOI)	1,011.11%
Global Interactive Technologies (GITS)	804.56%
Airnet Technology (ANTE)	801.49%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	756.27%
ThredUp (TDUP)	651.39%
Lixte Biotechnology (LIXTW)	617.86%
Americas Silver (USAS)	616.16%
mF International Limited Ordinary Shares (MFI)	606.21%
SRM Entertainment, Inc Common Stock (SRM)	587.72%
Dominari (DOMH)	581.67%
M3-Brigade Acquisition V Corp Warrant (MBAVW)	581.34%
Abits (ABTS)	489.34%
Immunoprecise Antibodies (IPA)	478.05%
Lizhi (SOGP)	464.5%
Epsium Enterprise Limited Ordinary Shares (EPSM)	454.91%
BitMine Immersion Technologies (BMNR)	431.95%